(Q37230103)

19 August 2017

Breast carcinoma developing in patients on hormone replacement therapy: a histological and immunohistological study (English)

1 reference

Hormone Replacement Therapy

19 August 2017

1 reference

1 reference

O'Connor IF

1

1 reference

19 August 2017

Shembekar MV

series ordinal

2

1 reference

19 August 2017

Shousha S

series ordinal

3

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 December 1998

1 reference

Journal of Clinical Pathology

19 August 2017

1 reference

19 August 2017

51

1 reference

19 August 2017

12

1 reference

19 August 2017

935-938

1 reference

Nuclear p53 protein accumulates preferentially in medullary and high-grade ductal but rarely in lobular breast carcinomas

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501032

Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501032

Bcl-2 protein expression and long-term survival in breast cancer

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501032

Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501032

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501032

Predictors of axillary lymph node metastases in patients with T1 breast carcinoma

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501032

Breast carcinoma in women under the age of 50: Relationship between p53 immunostaining, tumour grade, and axillary lymph node status.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501032

Clinical and biologic prognostic factors in breast cancer diagnosed during postmenopausal hormone replacement therapy

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501032

Prognostic characteristics in breast cancers after hormone replacement therapy

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501032

Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer

20 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10070338

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Paraffin section immunocytochemistry for estrogen receptor: the time has come

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10070338

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Bcl-2 and p53 expression in node-negative breast carcinoma: A study with long-term follow-up

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10070338

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/JCP.51.12.935

1 reference

19 August 2017

1 reference

19 August 2017

1 reference